Trademark: 88813289
Word
EBPIT
Status
Pending
Status Code
651
Status Date
Saturday, March 9, 2024
Serial Number
88813289
Mark Type
4000
Filing Date
Thursday, February 27, 2020

Trademark Owner History

Classifications
5 Protein arrays for medical diagnosis purposes; Protein arrays for therapeutic use for treating cancer, allergies, autoimmune disease, infection disease, and inflammatory disease; biopharmaceuticals for treatment of cancer, allergies, autoimmune disease, infection disease
1 Chemicals for scientific, laboratory and medical research; chemicals for use in the manufacture of pharmaceuticals; biochemicals, namely, antibodies for scientific, laboratory and medical research; proteins for immunoassay for detection, for diagnostic purposes, for therapeutic purposes, and for treatment of cancer, allergies, autoimmune disease, infection diseases
44 Medical services, namely, vaccinal pharmacologic treatment of autoimmune diseases such as psoriasis, Crohn's disease, rheumatoid arthritis, cancer, infectious diseases and allergies; health care services, namely, desensitization treatments for allergy; medical services, namely, immunotherapy in the fields of cancer, autoimmune, infectious disease and orphan diseases conditions in humans and veterinary applications; medical treatment of allergies, cancer, and auto-immune diseases destined to generate, in response to its administration in patients, the production of the patient's own antibodies
42 Development of pharmaceutical preparations and medicines; pharmaceutical research and development; software as a service (SAAS) services featuring artificial intelligence software for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining in the field of vaccinal pharmacologic treatment and allergy medications; platform as a service (PAAS) services featuring artificial intelligence software platforms for use in the pharmaceuticals and healthcare fields, namely, for diagnostic and therapeutic use, and for data mining for use in the field of vaccinal pharmacologic treatment and allergy medications
E BPIT

Trademark Events
Mar 22, 2024
Teas Response To Suspension Inquiry Received
Mar 9, 2024
Notification Of Inquiry As To Suspension E-Mailed
Mar 9, 2024
Inquiry To Suspension E-Mailed
Mar 9, 2024
Suspension Inquiry Written
Feb 16, 2024
Suspension Checked - To Attorney For Action
Aug 14, 2023
Notification Of Letter Of Suspension E-Mailed
Aug 14, 2023
Letter Of Suspension E-Mailed
Aug 14, 2023
Suspension Letter Written
Jun 29, 2023
Assigned To Examiner
May 4, 2023
Teas Response To Suspension Inquiry Received
Dec 1, 2022
Notification Of Inquiry As To Suspension E-Mailed
Dec 1, 2022
Inquiry To Suspension E-Mailed
Dec 1, 2022
Suspension Inquiry Written
Nov 23, 2022
Suspension Checked - To Attorney For Action
Oct 26, 2022
Assigned To Examiner
Apr 19, 2022
Notification Of Letter Of Suspension E-Mailed
Apr 19, 2022
Letter Of Suspension E-Mailed
Apr 19, 2022
Suspension Letter Written
Apr 14, 2022
Teas/Email Correspondence Entered
Apr 14, 2022
Correspondence Received In Law Office
Apr 13, 2022
Assigned To Lie
Apr 11, 2022
Teas Response To Suspension Inquiry Received
Oct 12, 2021
Notification Of Inquiry As To Suspension E-Mailed
Oct 12, 2021
Inquiry To Suspension E-Mailed
Oct 12, 2021
Suspension Inquiry Written
Apr 12, 2021
Notification Of Letter Of Suspension E-Mailed
Apr 12, 2021
Letter Of Suspension E-Mailed
Apr 12, 2021
Suspension Letter Written
Apr 12, 2021
Examiner's Amendment Entered
Apr 12, 2021
Notification Of Examiners Amendment E-Mailed
Apr 12, 2021
Examiners Amendment E-Mailed
Apr 12, 2021
Examiners Amendment -Written
Feb 18, 2021
Notification Of Letter Of Suspension E-Mailed
Feb 18, 2021
Letter Of Suspension E-Mailed
Feb 18, 2021
Suspension Letter Written
Feb 16, 2021
Teas/Email Correspondence Entered
Feb 16, 2021
Correspondence Received In Law Office
Feb 12, 2021
Assigned To Lie
Nov 11, 2020
Teas Response To Office Action Received
May 18, 2020
Notification Of Non-Final Action E-Mailed
May 18, 2020
Non-Final Action E-Mailed
May 18, 2020
Non-Final Action Written
May 18, 2020
Assigned To Examiner
Mar 5, 2020
New Application Office Supplied Data Entered
Mar 5, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24